Initiation Expected News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Initiation Expected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Initiation Expected Today - Breaking & Trending Today

Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants

Published: February 21, 2023

-- Infant Phase 2 Study Initiation Expected in the Second Quarter of 2023, with Initial Topline Safety, Tolerability and Immunogenicity Data by 2025 -- -- Based on Positive Topline VAX-24 Phase 1/2... | February 21, 2023

Source: marketscreener.com

Related Topics:

United StatesJim WassilJennifer ZibudaJanet GraesserGroupa StrepDrug AdministrationAdvisory Committee On Immunization PracticesExchange CommissionSutro Biopharma IncCorporate CommunicationsInitiation Of Pediatric Program In InfantsVaxcyte IncInitiation ExpectedSecond QuarterInitial Topline SafetyImmunogenicity DataPositive ToplineConcept Study ResultsPediatric ProgramInvestigational New DrugGrant PickeringChief Executive OfficerExecutive Vice PresidentChief Operating OfficerAdvisory Committee